檢索結果 - Terrance D. Barrett

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    RETRACTED: Obestatin reduces food intake and suppresses body weight gain in rodents

    RETRACTED: Obestatin reduces food intake and suppresses body weight gain in rodents 由 Guy Lagaud, Andy Young, Auzon Acena, Magda F. Morton, Terrance D. Barrett, Nigel P. Shankley

    出版 2007
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis

    TMPRSS6 as a Therapeutic Target for Disorders of Erythropoiesis and Iron Homeostasis 由 Tomas Ganz, Elizabeta Nemeth, Stefano Rivella, Paul Goldberg, Andrew R. Dibble, Michael L. McCaleb, Shuling Guo, Brett P. Monia, Terrance D. Barrett

    出版 2023
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus

    Effects of Canagliflozin on Heart Failure Outcomes Associated With Preserved and Reduced Ejection Fraction in Type 2 Diabetes Mellitus 由 Gemma A. Figtree, Karin Rådholm, Terrance D. Barrett, Vlado Perkovic, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, David R. Matthews, Wayne Shaw, Bruce Neal

    出版 2019
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  4. 4
    Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

    Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials 由 Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D. Barrett, Michele A. Weidner‐Wells, Hsiaowei Deng, David R. Matthews, Bruce Neal

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus

    Canagliflozin and Heart Failure in Type 2 Diabetes Mellitus 由 Karin Rådholm, Gemma A. Figtree, Vlado Perkovic, Scott D. Solomon, Kenneth W. Mahaffey, Dick de Zeeuw, Greg Fulcher, Terrance D. Barrett, Wayne Shaw, Mehul Desai, David R. Matthews, Bruce Neal

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats

    Prolyl hydroxylase inhibition corrects functional iron deficiency and inflammation-induced anaemia in rats 由 Terrance D. Barrett, Heather L. Palomino, Theresa I. Brondstetter, Kimon C. Kanelakis, Xiaodong Wu, Wen Yan, Katherine P Merton, Freddy Schoetens, Ying Jing, Judy Skaptason, Jingjin Gao, Da‐Thao Tran, Hariharan Venkatesan, Mark D. Rosen, Nigel P. Shankley, Michael H. Rabinowitz

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues

    Benzimidazole-2-pyrazole HIF Prolyl 4-Hydroxylase Inhibitors as Oral Erythropoietin Secretagogues 由 Mark D. Rosen, Hariharan Venkatesan, Hillary M. Peltier, Scott D. Bembenek, Kimon C. Kanelakis, Lucy X. Zhao, Barry E. Leonard, Frances M. Hocutt, Xiaodong Wu, Heather L. Palomino, Theresa I. Brondstetter, Peter V. Haugh, Laurence Cagnon, Wen Yan, L. Liotta, Andrew Young, Tara Mirzadegan, Nigel P. Shankley, Terrance D. Barrett, Michael H. Rabinowitz

    出版 2010
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: